focus -WSS

focus

author：Wikipedia 2025-09-03 12:08:51 - browse：13

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

explore

focus

WSS

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

NIH study of ME/CFS points to clear biological hallmarks

Obesity drugs seen as possible treatment for liver disease MASH

The Harvard botanist who searched for psychedelics in the Amazon

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Meadows told special counsel he could not recall Trump ever declassifying Mar

explore

focus

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

With competition flaring, obesity drug hits goal in liver disease study

Guidelines to prevent youth baseball injuries need more muscle

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Anesthesiologist group: stop taking Ozempic before surgery

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

The high cost of giving birth even with insurance

Obesity drugs seen as possible treatment for liver disease MASH

Peter Hotez and the public health issue of online harassment

Kellogg’s is going to war over Mexico’s nutrition label rules

entertainment

Roche's accidental data boosts hopes for anti

Alabama hospital puts IVF treatments on hold

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Alabama frozen embryo ruling has major implications for IVF clinics

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Listen: Vivek Ramaswamy's star turn & leaky drug data

explore

explore

focus

hotspot